Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act
HOME
/
Commentary & Opinion
/
Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act